Regeneron Pharmaceuticals
Nasdaq REGN · Tarrytown, NY
Works in Cardiovascular · Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Respiratory · Women's health
Regeneron Pharmaceuticals is a clinical trial sponsor based in Tarrytown, NY, listed as Nasdaq REGN. It has 122 active clinical trials with 75,157 planned participants, across 17 therapeutic areas. Since 2021 it has completed 102 trials and stopped 44 early.
Trial track record · since 2021
Financials · Nasdaq REGN
Pipeline · 122 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
9 approved drug applications with a product on the market.
Questions about Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is lead sponsor of 122 active clinical trials on ClinicalTrials.gov, with 75,157 planned participants, in Cardiovascular, Dermatology, ENT, Genetic & rare and other areas. Since 2021 it has completed 102 trials and stopped 44 early.
Regeneron Pharmaceuticals is based in Tarrytown, NY and is listed as Nasdaq REGN. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Regeneron Pharmaceuticals; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
Approve Suite is not affiliated with Regeneron Pharmaceuticals. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.